Member Info for LeBadinho

https://hemptoday.net/clear-leaders-emerge-from-crowd-chasing-uks-highly-sought-cbd-jackpot/

Asking for a clinic update since one week. Was asking for some kind of pipeline update for the clinics.

But i think they have a lot to do currently with rolling out the finger prick test.

And the launched the new website, which is way better than the old one

Great news for Phytovista Labs again. Hopefully they can receive an official governmental contract to support the cbd uk market regulation.

https://www.investegate.co.uk/goodbody-health-inc.--gdby-/rns/granted-home-office-controlled-drugs-licence/202204110700098738H/

Here the full list of Schedule 1 controlled drugs

https://www.legislation.gov.uk/uksi/2001/3998/schedule/1/made

Tradability seems to be a real problem in the UK. Really annoying.

Personally, I hope more news comes out before they officially release the 2021 financials.

https://health.goodbodyclinic.com/

... who sold 25k shares min every day since 31st of March? :D

Pls move on.

If you have any facts you can share with the rest fine otherwise take you money and look for another investment

Either you live with it or you invest elsewhere

i shared the news in several reddit groups to get more eyes on the stock. last time nearly 30k views have been created.

i also think thats massive.

but i don't get whats going on in north america.

List of all approved GDBY products and whitelabel clients

https://data.food.gov.uk/cbd-products/products-list?page=6&search=Goodbody

https://ceo.ca/@accesswire/goodbody-health-products-included-on-fsa-novel-foods

I had a conversation with GDBY this morning.

They continue to be on track.

New clinics are being added all the time. Yesterday they had posted on Instagram about over 150 Covid testing sites. The website currently lists only 140.

Covid sales are declining more slowly than expected. On one hand, that's good because sales continue to come in that weren't planned, but on the other hand, the team hasn't been able to fully support the rollout of blood testing clinics.

The rollout of blood testing will accelerate soon, as clinic staff training and test equipment rollout will be stepped up again from now on.

why should a CEO check with shareholders when he wants to adjust the strategy and direction of the company?

Do you really think Elon Musk asked his shareholders if it's okay to do Starlink?

Unless you are a minority shareholder and are allowed to contribute.

Unbelievable!

But the whole thing must be put into perspective and not spoken in absolutes.

Sativa Wellness and associated with it the new owners after the merge with Stillcanna are only responsible for one name change. A name change after the takeover is perfectly logical.

And this makes sense, since Stillcanna itself has never produced its own products. After the merger, the company was called Sativa Wellness and the Goodbody brand was created.

From my point of view - with 12 years of marketing experience - a perfectly logical step to rename it to Goodbody Health. The company name now perfectly fits with the claim "Know more. Live better".

Therefore, please leave the church in the village and focus on the essentials. Do not project your own frustration on things that are not there.

have you read the arden report in its entirety?
Where does it say that GDBY does not know what they are doing?

Sounds more like frustration to me. Or where does such a nonsensical thought come from?

So you're saying because they customize the company name/listing name to better match the company and the marketed brand is a weakness?

And they wouldn't know what they are doing?

From my point of view a totally sensible step with regard to marketing and understanding for both customers of the products and shareholders.

something interesting happened yesterday on ceo.ca/gdby.

The user WolfofOakville commented first. Who does not know him - he is the "financial guru" in various Discord groups.

He lives and invests by the motto "Fins don't lie". And is just wondering why one of his 4 out of 5 star ratings still hasn't gone up.

He's looking more deeply at the Arden report right now. Let's hope that it turns out well and vllt also GDBY sought the initiative.

From my point of view this user can influence others in their investment decision especially in North America.

Here again his Q3 2021 fins review. key statements:
"...but there is no denying these are fantastic financials. What appears to be hurting it's current value is its perceived reliance as a COVID play."

I had an exchange with him today. He "coincidentally" now realized that GDBY is more than just a Covid play.
Fingers crossed

Really good question. Problem with the CBD business is the heavy delay by the FSA decision. Planned March 2021!

So they focussed on other revenue streams. Have been successful and will be successful with their blood testing ue to the need in the UK.

If FSA Novel Food hopefully comes in the near future this could be interesting again.

Ask your questions enquiries@goodbodyhealth.com - Anne Tew

total count: 194